您正在浏览的是香港网站,香港证监会BJA907号,投资有风险,交易需谨慎
市场资讯

市场资讯

首页市场资讯个股相关资讯

Fate Therapeutics, Inc. (FATE)

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founde